Elevai Labs Inc. Contracts & Agreements
20 Contracts & Agreements
- Business Finance (4 contracts)
- Business Operations (2)
- Human Resources (2)
- Intellectual Property (3)
- Uncategorized (9)
- License Agreement, dated April 30, 2024, by and between the Company and MOA Life Plus Co., Ltd (Filed With SEC on May 2, 2024)
- Employment Agreement of Chris Kraneiss, dated August 6, 2022 (Filed With SEC on March 29, 2024)
- Employment Agreement of Brenda Buechler, dated June 24, 2022 (Filed With SEC on March 29, 2024)
- Employment Agreement of Jordan R. Plews, dated September 26, 2021 (Filed With SEC on March 29, 2024)
- Description Of Registered Securities (Filed With SEC on March 29, 2024)
- Director Offer Letter to Mr. George Kovalyov (Filed With SEC on March 7, 2024)
- License Agreement, dated January 16, 2024, by and between the Company and INmune Bio, Inc (Filed With SEC on January 22, 2024)
- Collaboration Agreement, dated November 28, 2023, by and between the Company and Yuva BioSciences, Inc (Filed With SEC on December 5, 2023)
- Form of Underwriters Warrants (Filed With SEC on November 24, 2023)
- Form of Lock-Up Agreement (Filed With SEC on November 24, 2023)
- Underwriting Agreement dated November 20, 2023, by and among Elevai Labs Inc., Univest Securities. and Webull Financial LLC (Filed With SEC on November 21, 2023)
- Form of Underwriting Agreement (Filed With SEC on September 29, 2023)
- Authorized Distributor and Trademark License Agreement, dated January 17, 2022, between Elevai Labs, Inc. and Dermapenworld Pty Ltd (Filed With SEC on September 29, 2023)
- Authorized Distributor Agreement, dated August 30, 2022, between Elevai Labs, Inc. and Refine USA, LLC (Filed With SEC on September 29, 2023)
- Form of Independent Director Offer Letter (Filed With SEC on September 29, 2023)
- Form of Advisory Agreement between Elevai Labs, Inc. and Braeden Lichti (Filed With SEC on September 29, 2023)
- Form of Amended and Restated Consulting Agreement between Elevai Labs, Inc. and NorthStrive Companies Inc (Filed With SEC on September 29, 2023)
- 2020 Equity Incentive Plan, as amended, and forms of award agreements thereunder (Filed With SEC on September 29, 2023)
- Stock Transfer Agreement, dated June 4, 2021, between BWL Investments Ltd. And Reactive Medical Labs Inc (Filed With SEC on September 29, 2023)
- Form of Common Stock Share Certificate (Filed With SEC on September 29, 2023)